Erlocip 100 mg contains Erlotinib, a targeted cancer therapy that belongs to the class of tyrosine kinase inhibitors (TKIs). It is primarily used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer, particularly in patients with specific EGFR (epidermal growth factor receptor) mutations. Erlotinib works by blocking signals that promote cancer cell growth and division, thereby slowing or stopping tumor progression.

• Targeted Cancer Therapy: Specifically acts on cancer cells with EGFR mutations.

• Effective in NSCLC & Pancreatic Cancer: Used as monotherapy or in combination with other treatments.

• Oral Administration: Convenient tablet form for at-home use.

• Improved Progression-Free Survival: Shown to delay cancer progression in suitable patients.

• Take the tablet orally with a glass of water.

• Timing: Best taken at least 1 hour before or 2 hours after meals.

• Do not crush or chew the tablet.

• Compliance: Take exactly as prescribed by your oncologist for optimal outcomes.

• Strength: 100 mg Erlotinib per tablet

• Route: Oral

• Typical Dosage: One tablet once daily, or as directed by a healthcare provider

• Duration: Depends on patient response and cancer type/stage

• Dose Adjustment: May be required based on tolerability and side effects

• Pregnancy & Breastfeeding: Not recommended; may harm the fetus or nursing baby.

• Liver & Kidney Monitoring: Regular liver function tests are advised.

• Avoid Sun Exposure: Increased risk of sunburn; use protective clothing and sunscreen.

• Drug Interactions: Inform your doctor about all medications, including herbal supplements.

• Common: Rash, diarrhea, fatigue, nausea, loss of appetite

• Serious: Lung inflammation (interstitial lung disease), liver enzyme elevation, GI bleeding

• Skin Reactions: Rash or acne-like eruptions may occur and are often manageable

• Seek Medical Help: If experiencing breathing difficulty, severe diarrhea, or yellowing of eyes/skin

• Store in a cool, dry place away from moisture and direct sunlight

• Keep out of reach of children

• Do not use after the expiry date

• Store in the original packaging to protect from moisture

Q1. What is Erlocip 100 mg used for?
A: It is used to treat non-small cell lung cancer and advanced pancreatic cancer, particularly in patients with EGFR mutations.

Q2. Can Erlocip cure cancer?
A: It is not a cure but helps slow or stop cancer growth and may improve survival.

Q3. How long will I need to take Erlotinib?
A: Duration depends on treatment response and side effects. Your oncologist will decide based on your condition.

Q4. Can I take this with food?
A: No. It should be taken on an empty stomach, either 1 hour before or 2 hours after meals.

Q5. Are there any precautions during treatment?
A: Yes. Avoid sun exposure, monitor for skin reactions, and report any signs of liver or lung issues immediately.